Non-ventilator hospital-acquired pneumonia: Risk factors for MDR pathogens and/or increased mortality in adults
Non-ventilator hospital-acquired pneumonia: Risk factors for MDR pathogens and/or increased mortality in adults
Risk factors for increased mortality:
Ventilatory support for HAP
Septic shock
Risk factor for MDR Pseudomonas aeruginosa, other gram-negative bacilli, and MRSA:
IV antibiotics within the past 90 days
Risk factors for MDR Pseudomonas aeruginosa and other gram-negative bacilli:
Colonization with or prior isolation of MDR Pseudomonas or other gram-negative bacilli
Risk factors for MRSA:
Treatment in a unit in which >20% of Staphylococcus aureus isolates are methicillin resistant
Treatment in a unit in which the prevalence of MRSA is not known
Colonization with or prior isolation of MRSA
ICU: intensive care unit; IV: intravenous; HAP: hospital-acquired pneumonia; MDR: multidrug resistant; MRSA: methicillin-resistant S. aureus.
Adapted from: Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63:e61.